Monthly Archives: May 2012


The +Motor Trend Magazine guys didn't quite make it to 200 mph on the 5 mile… 2

The +Motor Trend Magazine guys didn't quite make it to 200 mph on the 5 mile oval Chrysler's Arizona test track, but Randy Pobst came tantalizingly close at 196 mph. Ford SVT engineers set the benchmark at the 7.8 mile circular track at Nardo Italy and MT may go there next in their quest to hit this magic mark in a Mustang.

Google+: View post on Google+

Post imported by Google+Blog. Created By Daniel Treadwell.


Great story, great video

Reshared post from +Michael Floyd

Great story, great video. A quest for 200 mph.

Embedded Link

Gunning for 200 mph in the 2013 Ford Shelby GT500 – Motor Trend
Ford claims the 2013 Ford Shelby GT500 will break the 200-mph barrier, but we wanted to find out for ourselves. So we acquired a GT500, found a track, and enlisted racer and frequent Motor Trend hot s…

Google+: View post on Google+

Post imported by Google+Blog. Created By Daniel Treadwell.


Despite Google's attempts to incorporate more social signals like Facebook, it…

Despite Google's attempts to incorporate more social signals like Facebook, it may have had the right model for advertising all along.

Reshared post from +Jim Dalrymple

Embedded Link

Facebook fool’s gold
Facebook is no better at advertising than ValueClick or any other online ad network. They just happen to be able to correlate their customers slightly better…

Google+: View post on Google+

Post imported by Google+Blog. Created By Daniel Treadwell.


+Volvo Cars completed a real-world test of vehicle platooning

+Volvo Cars completed a real-world test of vehicle platooning. Essentially this a more advanced form of adaptive cruise control (ACC). ACC uses radar or laser sensors to measure the distance to the car ahead and then uses engine and brake control to hold your desired vehicle speed while maintaining a safe following distance.

This semi-autonomous platooning approach adds vehicle-to-vehicle communications that essentially lets the driver in the lead vehicle control all of the following vehicles in a virtual caravan.

The same technology has been demonstrated by other automakers including +Ford Motor Company and +General Motors. GM has publicly demonstrated (although not on open roads) platooning using its EN-V concepts. https://plus.google.com/u/0/114133424228405038490/posts/ASsuTcsch8y
#autonomousvehicles

Embedded Link

Autonomous three-car caravan completes 125-mile public road test
Project SARTRE (or Safe Road Trains for the Environment) has successfully completed a 125 mile test involving three autonomous cars on public roadways in Spain. What differentiates SARTRE from…

Google+: View post on Google+

Post imported by Google+Blog. Created By Daniel Treadwell.


Not convinced that human activity can can dramatically change the climate? Check… 1

Not convinced that human activity can can dramatically change the climate? Check out the story of Mo'ynaq in Uzbekistan. Mo'ynaq was once a thriving fishing town on the Aral Sea. Now the waterline lies 100 miles away.

Embedded Link

Mo‘ynaq – Graveyard of Ships in the Desert ~ Kuriositas
Aral Sea Ships

Google+: Reshared 1 times
Google+: View post on Google+

Post imported by Google+Blog. Created By Daniel Treadwell.


Why are squandering our limited resources developing, certifying and advertising… 1

Why are squandering our limited resources developing, certifying and advertising drugs like Latisse to enhance eye-lashes?

Embedded Link

Curing the Heartbreak of Insufficient Lashes? « Sam's Thoughts
Latisse. Never heard or it? I certainly hadn't until watching a marathon of the original Bob Newhart Show on the Hallmark Channel. Latisse is a prime example of why America spends more on health c…

Google+: View post on Google+

Post imported by Google+Blog. Created By Daniel Treadwell.


Curing the Heartbreak of Insufficient Lashes?

Latisse

Never heard or it? I certainly hadn’t until watching a marathon of the original Bob Newhart Show on the Hallmark Channel.

Latisse is a prime example of why America spends more on health care than any other country in the world while not having any improved outcomes to show for it.  We aren’t healthier, we don’t live longer and we’re generally not any happier than people in other developed countries.

So what is Latisse? It’s a prescription drug to treat thin or insufficient lashes. Yes eye-lashes, those little hairs that emerge from the edge of your eye-lids.  There are countless diseases that kill or disable hundreds of millions of people every year but I’ve never heard of anyone dying from thin eye-lashes.

So what? you might say, insurance companies probably don’t pay for it (mine doesn’t) so it’s not costing me anything. Despite patients paying for it out of pocket it still costs all of us.

We have limited financial and intellectual resources and developing new drugs typically costs well over $1 billion and occupies thousands of scientists. Even if we give Allergan, the company that makes Latisse, the benefit of the doubt and assume that Latisse was discovered by accident while looking for something actually useful, it still requires at least hundreds of millions of dollars and the time of FDA officials to run clinical trials before approvals. Those are resources that would be far better utilized elsewhere.

So why do we have drugs like Latisse on the market even though they don’t serve any useful purpose in improving human health? I think it’s because we allow companies to patent this stuff and then turn around and market directly to consumers on mass media. The entire fashion and cosmetics industry thrives on making women feel bad about the way they look. Drugs like this drive women to doctors to ask for these drugs, wasting the time of medical professionals and driving up costs for everyone.

As with most other modern drugs, the ads for Latisse outline a litany of potential side effects, any or all of which can lead to additional medical expenses. We have more than 50 million Americans without health insurance and yet we are squandering resources ridiculous drugs like Latisse.

One first step might be to require pharmaceutical companies to shoulder all of the costs of proving the safety of drugs like Latisse and Viagra that do nothing to improve health.

If we actually want to make any real progress on making health care more affordable while improving outcomes, we need to make changes to the drug patent system, get rid of direct to consumer advertising, refocus on health rather than cosmetic medicine.